肺原发恶性纤维组织细胞瘤30例分析  

Clinical Analysis of 30 Patients with Primary Malignant Fibrous Histiocytoma of the Lung

作　　者：吴琨[1] 汪浩[1] 

机构地区：[1]同济大学附属肺科医院胸外科,上海200433

出　　处：《中国临床医学》2007年第6期784-785,共2页Chinese Journal of Clinical Medicine

摘　　要：目的:研究经外科手术治疗的肺原发恶性纤维组织细胞瘤的临床特点及其预后。方法:回顾性分析经手术病理证实的肺原发恶性纤维组织细胞瘤30例,其中行根治切除24例(肺叶切除术18例,全肺切除术6例),姑息性切除术4例,2例剖胸探查术。结果:全组无手术死亡。随访时间1～21年,中位随访期6年。18例生存1年以上,11例生存3年以上,且5例生存超过5年。1年生存率为60%,3年生存率为36%。5年生存率为16.7%。死亡原因远处转移多见。结论:肺原发恶性纤维组织细胞瘤主要治疗手段为外科手术,本病的预后手术是否根治及肿瘤大小密切相关。早期发现,彻底切除,可改善预后,提高患者的生存率。Objective： To study the prognosis of surgical treatment of primary pulmonary malignant fibrous histocytoma （MFH）. Methods： Thirty patients with MFH disgnosed by histopathology were reviewed retrospectively. Twenty-four were treated by redical surgery resection, four were treated by indulgent surgery resection, two were by exploratory thoracotomy. Results： Eight of thirty patients were able to survive more than l year. Eleven of the them survived more than 3 years, and five were able to survive more than 5 years. The 1,3,5 years survival rates were 60%,36% and 16.7% respectively. The reason of death was metastasis. Conclusion： Surgical resection is the main device of the treatment of MFH. The prognosis have relation to the size of tumor and the redical resection. Early diagnosis, radicalresection may improve the climical outcome.

关 键 词：纤维组织细胞瘤 肺肿瘤 预后 

分 类 号：R734.2[医药卫生—肿瘤]